{
    "organizations": [],
    "uuid": "28f84a03e346cc8f5c9dc3cb22d8bfe60075d2ad",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-regeneron-pharma-says-enter-letter/brief-regeneron-pharma-says-enter-letter-agreement-relating-to-immuno-oncology-licensecollaboration-agreement-with-sanofi-idUSFWN1P30JI",
    "ord_in_thread": 0,
    "title": "BRIEF-Regeneron Pharma Says Enter Letter Agreement Relating To Immuno-Oncology License,Collaboration Agreement With Sanofi",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Regeneron Pharmaceuticals Inc:\n* REGENERON PHARMACEUTICALS-ON JAN 7,ENTERED LETTER AGREEMENT RELATING TO IMMUNO-ONCOLOGY LICENSE,COLLABORATION AGREEMENT WITH SANOFI BIOTECHNOLOGY SAS​\n* REGENERON PHARMACEUTICALS-PURSUANT TO LETTER AGREEMENT, CO, SANOFI SAS, AGREED TO INCREASE REGN2810 BUDGET AMOUNT TO $1.640 BILLION\n* REGENERON -ENTERED LETTER AGREEMENT ALSO RELATING TO AMONG OTHERS​, THE INVESTOR AGREEMENT DATED AS OF JAN 11, 2014, WITH SANOFI - SEC FILING\n* REGENERON PHARMACEUTICALS INC - ‍ ALSO AGREED TO REVISE REGN2810 GLOBAL DEVELOPMENT PLAN AND REGN2810 GLOBAL DEVELOPMENT BUDGET Source text: [ bit.ly/2qIaBGi ] Further company coverage:\n ",
    "published": "2018-01-08T20:13:00.000+02:00",
    "crawled": "2018-01-09T17:09:33.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "regeneron",
        "pharmaceutical",
        "inc",
        "regeneron",
        "jan",
        "entered",
        "letter",
        "agreement",
        "relating",
        "license",
        "collaboration",
        "agreement",
        "sanofi",
        "biotechnology",
        "regeneron",
        "letter",
        "agreement",
        "co",
        "sanofi",
        "sa",
        "agreed",
        "increase",
        "regn2810",
        "budget",
        "amount",
        "billion",
        "regeneron",
        "letter",
        "agreement",
        "also",
        "relating",
        "among",
        "investor",
        "agreement",
        "dated",
        "jan",
        "sanofi",
        "sec",
        "filing",
        "regeneron",
        "pharmaceutical",
        "inc",
        "also",
        "agreed",
        "revise",
        "regn2810",
        "global",
        "development",
        "plan",
        "regn2810",
        "global",
        "development",
        "budget",
        "source",
        "text",
        "company",
        "coverage"
    ]
}